Osteomyelitis

Definition/Routes

Haematogenous: blood-borne seeding from distant focus. DOMINANT in CHILDREN. Lodges in METAPHYSIS of long bones (sluggish looping capillary flow). Contiguous-focus: direct spread from adjacent infected soft tissue/joint/wound. DOMINANT in ADULTS. Vascular insufficiency osteomyelitis: contiguous-spread variant, poor circulation (DM, PVD) — predisposes to soft tissue breakdown AND impairs clearance.

Etiology

S. aureus = COMMONEST organism, ALL ages/routes. Anchors empirical Rx.

By context:

Neonates: S. aureus, GBS, GNB (E. coli etc)
Children: S. aureus predominant; Kingella kingae (HACEK) increasingly recognized, young children; S. pyogenes
Sickle cell disease: SALMONELLA disproportionately common (bowel infarction→translocation + impaired splenic clearance) — but S. aureus STILL commonest even here
Diabetic foot/vascular insufficiency: POLYMICROBIAL (S. aureus, strep, GNB, anaerobes)
IV drug users: Pseudomonas aeruginosa + S. aureus. Distinctive: AXIAL skeleton (vertebrae, SI joint, sternoclavicular) not long bones
Prosthetic joint infection: CoNS (S. epidermidis) + S. aureus — biofilm (mirrors prosthetic valve IE pathogenesis)
Tubercular osteomyelitis (M. tuberculosis): distinct, indolent. VERTEBRAL SPINE = Pott’s disease. Important differential, TB-endemic settings (India).

Pathogenesis

Local inflammation (pus, vascular thrombosis, ↑intraosseous pressure) → compromises bone’s OWN blood supply from within. SEQUESTRUM: dead poorly-perfused bone, walled off from immunity+antibiotics — persistent nidus for chronic/relapsing infection UNLESS surgically removed. INVOLUCRUM: new bone formation around infected area (periosteal elevation/irritation response). Untreated acute → chronic sequestrum-forming stage → often defeats antibiotics alone.

Clinical Manifestations

Acute: localized bone pain, fever, local inflammation (warmth/swelling/tenderness). Children: reluctance to bear weight/use limb. Chronic: indolent, persistent/intermittent pain, low-grade fever, DRAINING SINUS TRACT to skin (may close/reopen over years — distinctive pattern).

Laboratory Diagnosis

Blood culture: positive in meaningful proportion of hematogenous cases (esp. children) — spares invasive biopsy if positive. Bone biopsy (culture+histopath) = GOLD STANDARD, esp. contiguous-focus/chronic (blood culture less likely positive). Superficial wound/sinus swab = UNRELIABLE (surface colonizing flora, NOT true deep pathogen) — should NOT guide antibiotic choice. ESR/CRP: nonspecific, useful for TREATMENT MONITORING (declining trend = adequate control). Imaging: Plain X-ray — lags clinical disease by 1-2 weeks. MRI — most sensitive EARLY, defines soft tissue/marrow extent. Bone scan (Tc-99m) — if MRI unavailable/contraindicated.

Treatment

Prolonged antibiotics: MINIMUM 4-6 weeks acute osteomyelitis (longer than most infections — poor bone penetration, relapse risk). Guided by culture/susceptibility where obtained, not empirical alone. Surgical debridement: ESSENTIAL once sequestrum/significant necrotic bone forms, or abscess drainage. Antibiotics alone CANNOT clear dead avascular bone (same logic as gas gangrene/necrotizing fasciitis). Chronic osteomyelitis: often genuinely DIFFICULT TO CURE outright — management sometimes shifts to LONG-TERM SUPPRESSION rather than complete eradication.

Definition and Routes of Infection

Osteomyelitis is infection of bone, and its classification by route of entry matters directly for predicting the likely organism and the clinical course:

Haematogenous osteomyelitis — blood-borne seeding of bone from a distant infective focus (or transient bacteraemia), the dominant mechanism in children, where it characteristically lodges in the highly vascular metaphysis of long bones (the growth-plate-adjacent region, where sluggish, looping capillary blood flow favours bacterial settling).
Contiguous-focus osteomyelitis — direct spread from an adjacent infected soft tissue, joint, or open wound (surgical site, penetrating trauma, an infected diabetic foot ulcer) — the dominant mechanism in adults.
Osteomyelitis with vascular insufficiency — a variant of contiguous spread specifically in patients with poor peripheral circulation (diabetes mellitus, peripheral vascular disease), where the underlying vascular compromise both predisposes to the initial soft-tissue breakdown and impairs the host’s ability to clear the resulting bone infection.

Etiology

Staphylococcus aureus is the single most common causative organism across essentially every age group and every route of infection — a fact worth fixing precisely, since it anchors empirical antibiotic choice before culture results return. Beyond that dominant pathogen, the likely organism varies meaningfully by patient context:

Neonates: S. aureus, group B streptococcus, and Gram-negative bacilli (E. coli and others), reflecting the perinatal flora exposure.
Children: S. aureus predominates; Kingella kingae (a HACEK-group organism) is increasingly recognized as an important paediatric cause, particularly in young children, and Streptococcus pyogenes also occurs.
Sickle cell disease: a genuinely distinctive association — Salmonella species cause osteomyelitis disproportionately often in sickle cell patients (though S. aureus remains the single most common organism even in this group), thought to relate to bowel-wall infarction from sickling allowing Salmonella translocation, combined with impaired splenic clearance.
Diabetic foot / vascular insufficiency osteomyelitis: often polymicrobial, involving S. aureus, streptococci, Gram-negative rods, and anaerobes together, reflecting the underlying chronic, contiguous soft-tissue ulcer’s own flora.
IV drug users: Pseudomonas aeruginosa and S. aureus, with a distinctive predilection for axial skeleton sites (vertebrae, sacroiliac joint, sternoclavicular joint) rather than the long bones typical of other groups.
Prosthetic joint infection: coagulase-negative staphylococci (S. epidermidis) and S. aureus, reflecting biofilm formation on the implant surface — mirroring the same pathogenesis described for prosthetic valve endocarditis.
Tubercular osteomyelitis (M. tuberculosis): a distinct, more indolent entity, classically affecting the vertebral spine (Pott’s disease), important enough in TB-endemic settings like India to always sit on the differential for chronic, slowly progressive bone/joint pain.

Pathogenesis

Once bacteria establish infection within bone, the local inflammatory response — pus formation, vascular thrombosis, and rising intraosseous pressure — compromises the bone’s own blood supply from within, and this vascular compromise is what makes bone infection so difficult to clear: dead, poorly perfused bone (a sequestrum) can form, walled off from both host immune cells and systemic antibiotics, acting as a persistent nidus for chronic or relapsing infection unless surgically removed. Adjacent new bone formation around the infected area, in response to periosteal elevation and irritation, is called an involucrum. Untreated or inadequately treated acute osteomyelitis can progress to this chronic, sequestrum-forming stage, which then often defeats antibiotics alone.

Clinical Manifestations

Acute osteomyelitis presents with localized bone pain, fever, and local signs of inflammation (warmth, swelling, tenderness) over the affected site — in children, often with reluctance to bear weight or use the affected limb. Chronic osteomyelitis presents more indolently, with persistent or intermittently recurring pain, low-grade fever, and, characteristically, a draining sinus tract to the skin surface — a sinus that may close and reopen intermittently over years, a genuinely distinctive chronic-osteomyelitis pattern.

Laboratory Diagnosis

Blood culture is positive in a meaningful proportion of haematogenous cases (particularly in children) and, when positive, can spare the patient an invasive bone biopsy. Bone biopsy (culture plus histopathology) remains the diagnostic gold standard, particularly for contiguous-focus and chronic disease where blood culture is far less likely to be positive — a superficial wound or sinus-tract swab is notoriously unreliable, since it reflects surface colonizing flora rather than the true deep pathogen, and should not be relied upon to guide antibiotic choice. Inflammatory markers (ESR, CRP) are nonspecific but useful for monitoring treatment response, since a properly declining trend supports adequate source control and antibiotic efficacy. Imaging complements microbiological diagnosis: plain X-ray changes lag clinically evident disease by 1–2 weeks; MRI is the most sensitive early modality, also useful for defining the extent of soft-tissue and marrow involvement; bone scan (technetium-99m) is useful where MRI is unavailable or contraindicated.

Treatment

Prolonged antibiotic therapy is the rule — typically a minimum of 4–6 weeks for acute osteomyelitis (a duration considerably longer than for most other bacterial infections, reflecting poor antibiotic penetration into bone and the risk of relapse from incompletely cleared infection), guided by culture and susceptibility wherever a specimen was obtained rather than empirically alone. Surgical debridement is essential once a sequestrum or significant necrotic bone has formed, or for abscess drainage — antibiotics alone cannot clear dead, avascular bone, mirroring the same logic that makes surgical debridement essential in gas gangrene and necrotizing fasciitis. Chronic osteomyelitis, once established, is often genuinely difficult to cure outright and management sometimes shifts toward long-term suppression rather than complete eradication.